Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Ekso Bionics Holdings, Inc. (CHRN) had Return on Equity of -329.43% for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$2.14M |
|
$-6.88M |
|
$1.07M |
|
$1.07M |
|
$7.76M |
|
$-5.62M |
|
$-1.27M |
|
$-6.88M |
|
$-6.88M |
|
$-6.88M |
|
$-6.88M |
|
$-6.88M |
|
$-6.88M |
|
$-5.62M |
|
$-5.16M |
|
3.56M |
|
3.56M |
|
$-2.04 |
|
$-2.04 |
|
| Balance Sheet Financials | |
$14.05M |
|
$1.11M |
|
$5.62M |
|
$19.67M |
|
$9.09M |
|
$0.52M |
|
$4.84M |
|
$13.93M |
|
$2.09M |
|
$1.89M |
|
$5.74M |
|
3.56M |
|
| Cash Flow Statement Financials | |
$-2.12M |
|
-- |
|
$4.95M |
|
$1.17M |
|
$3.99M |
|
$2.82M |
|
$0.11M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.55 |
|
-- |
|
-- |
|
0.08 |
|
0.67 |
|
50.16% |
|
-262.40% |
|
-262.40% |
|
-- |
|
-321.58% |
|
-321.58% |
|
$-2.12M |
|
-- |
|
-- |
|
-- |
|
0.11 |
|
0.23 |
|
0.47 |
|
190.72 |
|
|
Return on Equity |
-329.43% |
-364.09% |
|
-35.01% |
|
-109.98% |
|
$1.61 |
|
$-0.60 |
|
$-0.60 |
|